Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226115 · ClinicalTrials.gov registry record
Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
A clinical trial of Colorectal Cancer and Colorectal Cancer Stage II, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07226115 is a study of Colorectal Cancer and Colorectal Cancer Stage II that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 200 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07226115, a study of Colorectal Cancer and Colorectal Cancer Stage II, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Although adjuvant chemotherapy improves survival after curative resection, its efficacy varies widely among patients. The absence of reliable predictive biomarkers often leads to overtreatment or undertreatment. This study aims to develop a machine learning-based predictive model for adjuvant chemotherapy response using tumor-derived alternative splicing signatures. By integrating RNA-seq data, splicing isoform and clinical outcomes, this study seeks to identify molecular predictors of treatment response and recurrence risk after surgery.
Conditions Studied
Interventions
- OTHER SPLICE
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-21 |
| Est. Completion | 2026-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226115
The ClinicalTrials.gov registry entry for NCT07226115 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (87% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which SPLICE is the first listed.
NCT07226115 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07226115 about?
NCT07226115 is a clinical study titled "Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer". Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Although adjuvant chemotherapy improves survival after curative resection, its efficacy varies widely among patients. The absence of reliable predictive biomarkers often leads to overtreatment or undertr...
What is the current status of trial NCT07226115?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-06-21. Estimated completion is 2026-06-18.
What conditions does trial NCT07226115 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Cancer Stage II, Colorectal Cancer Stage III, Colorectal Cancer Recurrent.
What interventions are being tested in trial NCT07226115?
The interventions under investigation include: SPLICE (OTHER).
Who is sponsoring clinical trial NCT07226115?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07226115 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.